ARCHIVES

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 23 | June 18, 2010

Download PDF Visit The Full Archive

Related Articles

US Files Motion To Dismiss Fisher Suit Over Database Flags

November 3, 1995

DCT Board Okays Concepts Of Four New Grant Projects, Four Competitive Contract Delays Chlordane Study

March 9, 1984

NCI advisors approved in concept the Institute’s plan to spend $24 million over five years for research on “patient navigator” programs.

March 26, 2004

Pharmacogenomics May Lead To Individualized Treatment

June 25, 2004

Senate Passes Budget; Broder; Fiscal 93 Great Year – Not

September 25, 1992

Clinical Trials Approved By NCI

November 26, 2010